Stay Connected with SynchNeuro

Be the first to hear about new product updates and opportunities to participate in research shaping the future of brain-metabolic health.

Your information will be securely stored and used only for the purposes you select above. Participation in research is voluntary and subject to a separate informed consent process. We respect your privacy—you can unsubscribe or update your preferences at any time

Consent Disclaimer

© 2025 SynchNeuro

About SynchNeuro

News

The startup incubator MedTech Innovator only launched in 2013, but it has had an immense impact on the industry. | Three MedTech Innovator startups showed off their diagnostic tech at the American Heart Association's 2025 Scientific Sessions in New Orleans.

Boomerang Ventures leads seed funding for SynchNeuro’s wearable brainwave sensor to non-invasively monitor glucose and metabolic health in real time.

Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis

At SynchNeuro, we are transforming how people monitor and manage their health with the world’s first non-invasive, brain-based continuous glucose monitor.

Our discreet behind-the-ear sensor analyzes brain signals to track glucose levels, sleep quality, and other key metabolic metrics—offering a pain-free, convenient, and inexpensive alternative to traditional monitoring.

Our work began with Dr. Casey Halpern’s research uncovering how brain activity shifts during glucose fluctuations. By identifying a strong correlation between EEG patterns and blood-sugar changes, his team made it possible to predict glucose levels using brain data. Building on these insights, we apply advanced machine-learning models to deliver accurate, real-time health information.

SynchNeuro is focused on making continuous, non-invasive monitoring accessible and practical, helping individuals—especially those with prediabetes—identify risks earlier and take control of their metabolic health.